The large concentration difference between GSH and GSSG creates a dynamic-range challenge, requiring calibration and dilution procedures that maintain GSSG sensitivity without GSH saturation or carryover
Typically used when aiming for ~3 mg/week in divided doses
350 Mitochondrial dysfunction in Schwann cells triggers alterations in lipid metabolism, leading to myelin sheath dysfunction and accumulation of toxic lipid intermediates, which cause axonal degeneration and neuropathy
Results: Significant reduction in modified MASI was observed in patients treated with topical and oral glutathione ( p =0.011) and ( p =0.007) respectively, while patients treated with topical or oral placebo had no response
Br J Clin Pharmacol 1986;22:359-62
H., Dinsdale, D., & Nemery, B